Data as of Sep 12, 2026. Both funds on the fields they both publish, from the same sources.
RDVY vs XLV: how they differ
RDVY and XLV hold 2% of their weight in the same names, and RDVY returned more over the year.
First Trust Rising Dividend Achievers ETF and State Street(R) Health Care Select Sector SPDR(R) ETF.
What they hold in common
By the books each fund has filed, RDVY and XLV hold 2% of their money in the same securities at the same weight.
| Holding | RDVY | XLV |
|---|---|---|
| REGENERON PHARMACEUTICALS INC | 0.85% | 1.09% |
| ABBOTT LABORATORIES | 0.58% | 2.76% |
| ELEVANCE HEALTH INC | 0.54% | 1.47% |
| RESMED INC | 1.11% | 0.49% |
| Only in RDVY | Only in XLV |
|---|---|
| APPLIED MATERIALS INC 4.69% | Eli Lilly & Co 16.56% |
| LAM RESEARCH CORP 4.42% | Johnson & Johnson 10.67% |
| KLA CORP 4.14% | AbbVie Inc 7.76% |
| GE VERNOVA INC 2.80% | UnitedHealth Group Inc 6.59% |
| BANK OF NEW YORK MELLON CORP (THE) 2.15% | Merck & Co Inc 5.54% |
| GE AEROSPACE 2.13% | Amgen Inc 3.41% |
| ALPHABET INC 2.12% | Thermo Fisher Scientific Inc 3.25% |
| WILLIAMS SONOMA INC 2.12% | Gilead Sciences Inc 2.74% |
Weight overlap is an ETFIQ calculation: for every security both funds hold, the smaller of the two weights, summed. Above 50%, holding both is close to holding one of them twice. Holdings dated Jun 30, 2026.
| RDVY First Trust Rising Dividend Achievers ETF | XLV State Street(R) Health Care Select Sector SPDR(R) ETF | |
|---|---|---|
| Where it sits | Core index fund | Core index fund |
| Issuer | First Trust | State Street |
| What it is | First Rising Dividend Achievers | Health care |
| Total return, 1 year | +22.0% | +20.4% |
| S&P 500 over the same days | +17.5% | +17.5% |
| Gap to the S&P 500 | +4.5 pts | +2.9 pts |
| Expense ratio | 0.47% | 0.08% |
| Already in the S&P 500 | 94.4% | 100.0% |
| Holdings | 71 | 59 |
RDVY in plain words
RDVY is an index equity fund tracking the First Rising Dividend Achievers. Over the year to Sep 11, 2026 it returned +22.0% with distributions reinvested, against +17.5% for the S&P 500 and +23.0% for the Nasdaq-100. The prospectus expense ratio is 0.47% a year. By its holdings filed for Jun 30, 2026, 94% of the fund by weight is stocks the S&P 500 also holds, across 71 positions, with the top ten at 28.6%. It sat 3.9% below its high of Aug 13, 2026 on Sep 11, 2026.
XLV in plain words
XLV is an index equity fund tracking the Health care. Over the year to Sep 11, 2026 it returned +20.4% with distributions reinvested, against +17.5% for the S&P 500 and +23.0% for the Nasdaq-100. The prospectus expense ratio is 0.08% a year. By its holdings filed for Jun 30, 2026, 100% of the fund by weight is stocks the S&P 500 also holds, across 59 positions, with the top ten at 61.7%. It sat 5.9% below its high of Aug 19, 2026 on Sep 11, 2026.
Questions people ask
- Which returned more over the last year, RDVY or XLV?
- In the year to Sep 12, 2026, with distributions reinvested, RDVY returned +22.0% and XLV returned +20.4%, so RDVY returned more. One year is one year; the longer windows are in the table.
- Which is cheaper, RDVY or XLV?
- RDVY charges 0.47% a year and XLV charges 0.08%, so XLV is cheaper. Fees come from each fund's prospectus.
- How much do RDVY and XLV overlap with the S&P 500?
- By their latest filed holdings, 94% of RDVY and 100% of XLV by weight is stocks the S&P 500 already holds. Between the two funds, 2% of their books are the same securities at the same weight.
Other comparisons
Where to next
Where these figures came from
ETFIQ links to the documents behind every figure. It is not affiliated with any issuer, and a link is not an endorsement.
Cite this page. ETFIQ, RDVY against XLV, data as of Sep 12, 2026. https://etfiq.com/compare/any/RDVY-XLV Free to use with attribution; the underlying files are at Open data.
A comparison is not a recommendation. Standards and sources